Health
COVID-19 survivors urged to donate blood for trials – The Australian Financial Review
Men recovering from COVID-19 are being urgently sought to donate their antibodies for two treatment trials to help acute hospitalised patients.
The other, REMAP-CAP, focuses on critically ill COVID-19 patients who require intensive care. Convalescent plasma is being used with antiviral medications, immune function modulators, anti-coagulation therapy to assess the impact on acute patients.
Anyone who has had COVID-19 but has been free of it for 28 days is eligible to donate. “We would encourage people to come forward,” Dr Daly said.
Men who are recovering from COVID-19 are being sought in particular, because research suggests they hav…
-
Noosa News14 hours agoWoman hospitalised with life-threatening facial burns
-
Noosa News17 hours agoMore than $25m in workers’ compensation claims relating to e-scooter and e-bike injuries made in Queensland over five-year period
-
Noosa News14 hours agoScenic Rim’s Summer Land farm aims to make camel meat, milk mainstream
-
General24 hours agoOzzy Osbourne fans flock to Birmingham to pay tribute ahead of funeral